Is QBIO or O a better dividend investment in 2026?

QBIO currently yields 2000000.00% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: QBIO offers higher current income.

What is the dividend yield difference between QBIO and O?

QBIO has a forward dividend yield of 2000000.00% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 1999994.72 percentage points.

Home › Compare › QBIO vs O

QBIO vs O: Dividend Comparison 2026

QBIO yields 2000000.00% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QBIO wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QBIO

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full QBIO calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.15

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,102.74

Full O calculator →

Portfolio growth — QBIO vs O

📍 QBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QBIO	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QBIO + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QBIO pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QBIO

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$449.12/yr

After 10yr DRIP, annual income (after tax)

$4,337.33/yr

At 15% tax rate, QBIO beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QBIO + O for your $10,000?

QBIO: 50%O: 50%

100% O50/50100% QBIO

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

QBIO

No analyst data

Altman Z

-33.2

Piotroski

3/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.7% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QBIO buys

O buys

No recent congressional trades found for QBIO or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQBIOO

Forward yield	2000000.00% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$4.879226400974806e+39M	$34.2K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$5,102.74
Total dividends collected	$4.879195005460081e+39M	$20.7K ✓
Payment frequency	quarterly	monthly
Sector	Stock	REIT

Year-by-year: QBIO vs O ($10,000, DRIP)

Year	QBIO Portfolio	QBIO Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$10,818	$608.16	+$200.00M → QBIO
2	$3,738,731,768,458	$3,738,517,757,009.35	$11,787	$741.68	+$3738731.76M → QBIO
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$12,946	$911.00	+$65315062866.92M → QBIO
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$14,345	$1,127.94	+$1066400830062625.00M → QBIO
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$16,056	$1,409.05	+$16272182796453826560.00M → QBIO
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$18,171	$1,777.83	+$2.3205424011366188e+23M → QBIO
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$20,820	$2,268.21	+$3.0927990661046884e+27M → QBIO
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$24,188	$2,929.90	+$3.8524105697352695e+31M → QBIO
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$28,533	$3,837.11	+$4.484688260147987e+35M → QBIO
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$34,235	$5,102.74	+$4.879226400974806e+39M → QBIO

QBIO vs O: Complete Analysis 2026

QBIO — Stock

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

Full QBIO Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this QBIO vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QBIO vs SCHD QBIO vs JEPI QBIO vs KO QBIO vs MAIN QBIO vs STAG QBIO vs ADC QBIO vs NNN QBIO vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.